Wells Fargo Maintains Equal-Weight on Merck & Co, Raises Price Target to $135
Portfolio Pulse from Benzinga Newsdesk
Wells Fargo analyst Mohit Bansal has maintained an Equal-Weight rating on Merck & Co (NYSE:MRK) and increased the price target from $130 to $135.
March 27, 2024 | 12:41 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Wells Fargo has maintained an Equal-Weight rating on Merck & Co and raised the price target from $130 to $135.
The increase in price target by Wells Fargo suggests a positive outlook on Merck & Co's stock, potentially leading to a short-term increase in its stock price. The Equal-Weight rating indicates that the stock is expected to perform in line with the market or sector average, but the raised target price signals analyst confidence in the company's prospects.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100